Search

Sutureless aortic valve replacement (SAVR) is indicated for patients with aortic stenosis. Three treatment modalities for aortic stenosis: SAVR, conventional aortic valve replacement (CAVR) and transcatheter aortic valve implantation (TAVI) were compared in the CEA.. In line with the Valve Academic Research Consortium-2 Guidelines the time horizon chosen was 30 days. The network meta-analysis results showed that, SAVR was associated with a lower probabilistic rate of death (2.3%) compared to CAVR (4.5%) and TAVI (4.4%), suggesting that SAVR is associated with better survival. [Extracted from the article]